E. Krognes - Insider Trading & Ownership

Location
863 Mitten Road, Suite 102, Burlingame, CA
Summary
The estimated net worth of E. Krognes is at least $14.8M dollars as of October 2, 2025. E. Krognes is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $13.4M. E. Krognes is the Director of Guardant Health, Inc. and owns shares of Guardant Health, Inc. (GH) stock worth about $1.31M. E. Krognes is the Director of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $111K.
Signature
/s/ John Saia, as attorney-in-fact for Steve Krognes
All Insider Reports
All Insider Reports

Ownership of E. Krognes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $13.4M -$677K -4.82% Jun 3, 2025
GH Guardant Health, Inc. Director $1.31M Sep 30, 2025
PLRX PLIANT THERAPEUTICS, INC. Director $111K Jun 5, 2025
GRTS Gritstone bio, Inc. Director Jun 16, 2023

Insider Transactions Reported by E. Krognes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.